Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality

Key clinical point: Patients with viral hepatitis may live longer after treatment with direct-acting antiviral agents, but their risk of extrahepatic causes of death may rise as a result.

Major finding: Among patients with hepatitis C infection, age-standardized mortality due to diabetes increased at a rate of 3.3% per year from 2014 to 2017.

Study details: A retrospective study evaluating causes of mortality among approximately 28 million patients with chronic liver disease.

Disclosures: The investigators reported no external funding or conflicts of interest.


Kim D et al. Gastroenterology. 2019 Jun 25. doi: 10.1053/j.gastro.2019.06.026.